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Diabetes causes microvascular complications in 
the retina, which commonly manifest as diabetic 
retinopathy (DR). DR is the leading cause of 
blindness in the current worldwide diabetes 
epidemic. Therefore, screening for DR is worthwhile 
and provides an opportunity to detect other comorbidities, such as 
glaucoma and age-related macular degeneration. Examination of 
the posterior pole of the eye (optic disc, retinal arcades and macula) 
detects a high proportion of patients with referable or treatable 
pathology. In addition, vital information is obtained regarding the 
state of the microvascular system in general. 
Direct fundoscopy has traditionally been the method of examining 
the fundus at the primary healthcare level. The pressure of too many 
patients and de-skilling of healthcare workers have resulted in fewer 
patients being screened for DR at the primary level. However, recent 
advances in digital camera technology have made it possible to 
acquire high-resolution images of the fundus to enable screening 
for DR. Many countries have established DR screening systems that 
screen all diabetics for DR annually. South Africa (SA) has lagged 
behind in this regard, with the result that many diabetics are not 
screened. There is also a high default rate among those patients who 
are screened, reflecting a poor understanding of the necessity of the 
screening and ignorance of the import of the DR level or ‘score’ at 
any point in time. 
In response, the Ophthalmology Society of Southern Africa (OSSA) 
has developed a system for a national DR screening programme. It is 
anticipated that this will incorporate screening at all levels from the 
clinic to the specialist. 
Diabetic retinopathy screening may be described as structured 
or opportunistic. Examples of structured programmes would be the 
programmes established in the UK, funded by governments or managed 
health organisations. Such programmes work best in situations where the 
state is the major healthcare provider and there is not necessarily a strong 
link between the healthcare provider and the patient. Germany provides 
an example of a country where DR screening tends to be opportunistic 
and where patients access the services of their chosen healthcare provider 
in more individualised ‘doctor-patient’ relationships. Opportunistic 
systems tend to be funded by the individual. 
In SA, the public sector tends to follow the structured model and 
the private sector tends toward the opportunistic model. There are 
recommendations for screening in place,[1] but there is no central register, 
recall system or even a common grading system. A local exception to this 
is the Centre for Diabetes and Endocrinology (CDE) programme for DR 
screening, which has demonstrated the benefit of a structured approach 
to DR screening in SA conditions. It has also highlighted some of the 
modelling pitfalls where patients may be inadvertently referred away 
from their established eye caregivers (opportunistic model) for screening 
to other practitioners (structured model). 
There is a general lack of education among patients regarding 
the need for screening. Private patients are often not referred for 
screening. This may be simply because the primary caregiver does 
not think of it and patients are not aware enough to request screening. 
The public sector is generally swamped with established pathology, 
to the extent that further screening is discouraged as it simply makes 
the backlog greater. Many diabetics in SA are therefore not screened 
for DR and often present to the ophthalmologist for the first time 
with vision loss due to advanced eye disease. Both our opportunistic 
and structured systems have failed these patients, many of whom 
face blindness. There is an urgent need to turn this situation around 
and to enable patients to know the level of severity of their DR and 
provide them with the necessary information to modify their risk 
factors and change their health-seeking behaviour. 
Laser photocoagulation has been the mainstay of treatment for 
DR. It continues to be the key intervention, with new technologies 
allowing faster and less invasive therapies. Laser is, however 
inherently destructive. The most dramatic recent advance in the 
management of DR has been the use of intravitreal injections of 
anti-vascular endothelial growth factor (anti-VEGF) agents. These 
agents have demonstrated an ability to stabilise and control most of 
the sight-threatening DR-related disease. They are effective against 
the proliferative and maculopathic elements of the disease. This 
has meant that there is a significant increase in the ability of the 
ophthalmologist to treat DR and prevent blindness. 
The OSSA proposes a low-cost system that makes use of the current 
resources available to improve access to screening, and is adaptable to 
the local conditions within the structured or opportunistic models. 
Screening for diabetic retinopathy (DR) not only allows for detection of microvascular complications, but for detection of other 
comorbidities. Recent advances in digital camera technology have improved screening for DR and many countries have established systems 
that screen all diabetics for DR annually. However, South Africa has lagged behind due to pressures at the primary care level, with the result 
that many diabetics are not screened. In response, the Ophthalmology Society of Southern Africa has developed a low-cost ‘scorecard’ 
system for a national DR screening programme. 
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A public awareness campaign needs to be undertaken to motivate 
diabetic patients to seek screening. 
All willing and able screeners need to be recruited and trained so 
as to be able to offer access to screening. Direct fundoscopy, fundus 
photography, slit-lamp and indirect ophthalmoscopy all play a role 
as individual modalities, and in combination, in the examination 
for diabetic eye disease. The OSSA is aware that these are often not 
available or not used for screening by the primary caregiver. We wish 
to promote our screening programme as an educational exercise for 
patients and caregivers. Where patients are not able to access screening 
from their primary caregiver we would encourage referral for screening 
to an appropriate centre. This may require that the patient be referred 
to the private sector from the public sector or vice versa. It may mean 
that they may be referred from a GP to another GP, an optometrist or 
an ophthalmologist. We propose an accreditation system to provide 
quality assurance (QA).
The OSSA DR screening system
Our goal is to develop a patient-driven diabetic screening programme 
that identifies and informs health-seeking behaviour of high-risk patients. 
The realities of the healthcare scenario in SA at present mean that 
there will not be a systematic screening system in the immediate 
future. The key principle of the OSSA system is the clear transfer 
of responsibility for health-keeping to the patient. We want to make 
it possible for all levels of practitioner to participate. This would 
include nursing sisters, optometrists, GPs, specialist physicians, 
endocrinologists and ophthalmologists. 
There are four key elements of the screening system, which make 
use of the best elements of the opportunistic system and some of the 
benefits of the structured system:
1. A common DR screening grading system. The Scottish DR 
grading system has been adopted to develop a simple feature-
based grading system (Fig. 1). It is hierarchical with increasing 
severity from microaneurysms < blot haemorrhages < intraretinal 
microvascular anomalies < venous beading < new vessels. It is 
based on the examination of the posterior pole of the eye (the optic 
disc, temporal arcades and macular area). This is highly suited 
to examination with a direct ophthalmoscope and has a well-
established evidence base for single field digital fundus screening.
2. An internet-based DR database and patient-tracking system. This is 
a closed user, group database that functions as a medical record for 
the participant screeners’ patients and a common database for the 
whole screening programme. Screeners can access their own patients 
via their file numbers. In a situation where a patient migrates between 
systems or practices their database records can be accessed by means 
of their individual database number. Confidentiality is maintained by 
the common database being ‘denatured’. Patient consent to be loaded 
onto the database is requested by the screener.
3. A patient-held record (PHR). It is common for patients to leave a 
consultation without knowing what was found and its significance. 
This means that they cannot relay vital information to their 
families and primary caregivers. The communication between the 
point of screening and the primary caregiver is often inadequate. 
When the patient meets the primary caregiver, there is often more 
confusion as there are a number of possible classifications of DR 
and the primary caregiver may not be familiar with these. The PHR 
attempts to bridge these gaps using the popular concept of a sports 
‘score’. The PHR ‘scorecard’ is marked with the observed grade, the 
follow-up date and any other disease present. The patient takes the 
record as a reminder of the follow-up and as a communication tool. 
Fig. 1. Examples of the OSSA DR screening system taken from the PHR.
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The card is marked with their database number as a cross reference 
should they migrate between practitioners. 
Control of systemic risk remains the most important factor in 
preventing diabetic eye disease. Systemic risk for progression to 
sight-threatening eye disease is incorporated into the PHR. A risk 
calculator has been developed for SA conditions in collaboration 
with Prof. Einar Steffansson, who developed a risk calculator 
based on the outcomes observed in a large Danish cohort.[2] 
Systemic risk is calculated and the outcome drawn onto a ‘rev 
counter’ that is placed next to the ‘no retinopathy’ photographs 
(Fig. 1). This helps dispel the possible misconception that no 
retinopathy means ‘no need to control the systemic risk factors’.
4. A QA system. A collaboration has been established with the 
University of Aberdeen to make use of their digital QA system. 
This internet-based system has been in use in Scotland to evaluate 
graders. The system plots the sensitivity and specificity of graders 
on a receiver operating characteristic (ROC) curve. This allows 
graders to see where they are with respect to their peers. The system 
has been found to be highly motivational and educational. The 
graders generally show improvement in QA outcomes over time.
The Diabetic Retinopathy Register 
The central point of communication and resource is the freely 
accessible online database to be found at www.diabeticregister.
co.za (contact S Cook to receive a link to enrol on the site). The site 
contains a download function for resources such as the PHR and 
online training. The risk calculator for calculating systemic risk of 
sight-threatening retinopathy is included in the online screening 
and is available from Risk Medical Solutions (www.riskafrica.co.za). 
PHRs can be ordered directly from Harry’s Printers (contact deena@
harrysprinters.co.za). OSSA members have indicated their willingness 
to provide training for screening. All levels of healthcare practitioners 
are encouraged to participate. 
Conclusion
The OSSA screening programme will systematically raise the level of 
knowledge of DR among patients and their caregivers. We anticipate 
that informed patients will make better choices regarding their 
health-seeking behaviour. Our system makes the most of the current 
resources by providing immediate access to a common platform 
and communication methodology. The involvement of all levels of 
healthcare practitioner should make access to screening much easier 
for patients. Appropriate, timely referral will afford patients the best 
possible opportunity to retain their sight.
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